Tata Chemicals Q1 FY27 Results Analysis: PAT Grows 11.7%, Soda Ash Downturn Persists (TATACHEM)
CompoundingAI Research
Updated July 27, 2026
2 min read
Negative
Tata Chemicals Ltd's Q1 FY27 numbers came in soft. Here's a quick read of what worked, what to watch, and what management said.
Quick Details| Results date | July 27, 2026 |
|---|
| Quarter | Q1 FY 2026-2027 |
|---|
| Revenue (Q1) | Rs. 4,255.00 Cr (+14.41% YoY) |
|---|
| PAT (Q1) | Rs. 60.00 Cr |
|---|
| EBITDA margin | 13.04% (-441 bps YoY) |
|---|
| EPS (Q1) | Rs. -0.67 |
|---|
| Market cap | Rs. 17,827.29 Cr |
|---|
| CMP | Rs. 698.90 |
|---|
Quarter Snapshot
Consolidated results show a strong sequential revenue recovery but the soda ash cycle downturn continues to depress earnings, with Industrial Essentials posting an EBIT loss. Standalone India business performed well with 11.7% PAT growth, but subsidiary losses widened the drag. No management guidance or numeric targets were provided in the filing, limiting the ability to assess beats or inflections.
Key Investment Insights
Key Positives
- Revenue from operations grew 14.4% YoY to Rs.4,255 crore, partly aided by INR depreciation.
- Standalone PAT grew 11.7% YoY to Rs.343 crore, the 8th consecutive quarter of YoY PAT growth.
- Farm Essentials segment EBIT margin expanded from 12.75% to 15.26% YoY, the only segment with margin expansion.
- EBITDA of Rs.555 crore was a strong sequential recovery from Rs.274 crore in Q4FY26 (+102.6% QoQ).
- Current ratio improved to 1.52x from 1.07x, and net worth increased to Rs.22,794 crore driven by OCI gains.
Risk Factors
- PAT attributable to owners turned negative at (Rs.17) crore vs Rs.252 crore profit in Q1FY26, driven by subsidiary drag of Rs.360 crore.
- EBITDA margin compressed 441 bps YoY to 13.04% from 17.45%, as total expenses grew faster than revenue.
- Industrial Essentials segment reported an EBIT loss of Rs.70 crore vs profit of Rs.131 crore YoY, confirming soda ash pricing pressure.
- Consolidated earnings were aided by a one-time provision reversal of Rs.43 crore; normalized PAT-to-owners remains negative at (Rs.40.46) crore.
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now